Home SPPI
0.4262
  Price2.88%   -0.0127
 
loading
Sep-26-22 12:09PM Spectrum (SPPI) Down as FDA Panel Votes Against NSCLC DrugZacks Investment Research
03:43AM Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From FridayBenzinga
Sep-23-22 02:57AM Dow Hits New 2022 Low; Gold Falls SharplyBenzinga
01:50AM Despite Regulatory Setback, Spectrum Still "Unique Investment Opportunity," Says AnalystBenzinga
Sep-23-22 12:16PM Why Shares Of Oil & Gas Companies Are Trading Lower, Here Are 62 Stocks Moving In Friday's Mid-Day SessionBenzinga
12:15PM Nasdaq Tumbles Over 200 Points; Crude Oil Drops SharplyBenzinga
Sep-23-22 07:16AM Why T2 Biosystems Is Trading Higher By 18%; Here Are 28 Stocks Moving PremarketBenzinga
Sep-21-22 02:20AM With Upcoming Contentious Meeting, This Analyst Cuts Price Target On Spectrum PharmaBenzinga
03:04AM Why SOBR Safe Shares Surged Around 233%; Here Are 68 Biggest Movers From YesterdayBenzinga
Sep-20-22 02:59AM Dow Dips 400 Points; Ford Shares SlideBenzinga
12:41PM Why Virios Therapeutics Is Trading Lower By 75%, Here Are 44 Stocks Moving In Tuesday's Mid-Day SessionBenzinga
Sep-20-22 12:03PM Nasdaq Down 50 Points; Crude Oil Falls SharplyBenzinga
Sep-12-22 12:45PM Why Ventyx Biosciences Is Trading Higher By 70%, Here Are 46 Stocks Moving In Monday's Mid-Day SessionBenzinga
12:06PM HC Wainwright & Co. Maintains Buy Rating for Spectrum Pharmaceuticals: Here's What You Need To KnowBenzinga
Sep-12-22 11:26AM Spectrum Pharmaceuticals (SPPI) Gets Nod for Rolvedon InjectionZacks Investment Research
07:35AM Bristol-Myers Squibb, Carvana And Some Other Big Stocks Recording Gains In Today's Pre-Market SessionBenzinga
Sep-12-22 06:30AM Why Clovis Oncology Is Trading Higher By 14%; Here Are 28 Stocks Moving PremarketBenzinga
Sep-09-22 06:37AM Penny Stocks To Buy: The Good, Bad, & Ugly & 3 To Watch NowPennyStocks
Aug-12-22 03:30AM Spectrum Pharmaceuticals (SPPI) Q2 2022 Earnings Call TranscriptThe Motley Fool
Jun-02-22 03:56AM Hot Penny Stocks Under $1 To Watch In JunePennyStocks
May-13-22 12:00PM Spectrum Pharmaceuticals (SPPI) Q1 2022 Earnings Call TranscriptThe Motley Fool
May-12-22 08:42AM The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And MoreBenzinga
Spectrum Pharmaceuticals, Inc. develops and commercializes oncology and hematology drug products. The company markets six drug products, including FUSILEV for patients with metastatic colorectal cancer and rescue after high-dose methotrexate therapy in osteosarcoma, and to diminish toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdosage of folic acid antagonists; FOLOTYN, a folate analogue metabolic inhibitor for peripheral T-cell lymphoma (PTCL); ZEVALIN injection for patients with B-cell non-Hodgkin's lymphoma; MARQIBO, a sphingomyelin/cholesterol liposome-encapsulated formulation for adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia; BELEODAQ injection for PTCL; and EVOMELA for use as a conditioning treatment prior to autologous stem cell transplant in multiple myeloma patients. It is also developing POZIOTINIB for treating breast and lung cancer; ROLONTIS for chemotherapy-induced neutropenia; and QAPZOLA for intravesical instillation in post-transurethral resection of bladder tumors in patients with non-muscle invasive bladder cancer. The company sells its drugs through group purchasing organizations, wholesalers, and directly in the United States; and through distributors in Europe. Spectrum Pharmaceuticals, Inc. has licensing and development agreement with Cell Therapeutics, Inc.; license agreement with Merck & Cie AG, Sloan-Kettering Institute, and Cydex Pharmaceuticals, Inc.; development and commercialization collaboration agreement with Allergan, Inc.; collaboration agreement with Nippon Kayaku Co., LTD.; licensing and collaboration agreement with Onxeo DK; and co-development and commercialization agreement with Hanmi Pharmaceutical Company. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was founded in 1987 and is headquartered in Henderson, Nevada.
Cap:    |  Volume (24h):